规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
---|---|---|---|---|---|---|---|---|---|
0mg | ¥ ȍŨDZƴƴ | > | -- | -- | -- | -- | -- | ¥ ȍŨDZƴƴ | - + |
250mg | ¥ ŶƴDZƴƴ | > | -- | -- | -- | -- | -- | ¥ ŶƴDZƴƴ | - + |
1g | ¥ ĸƬǙDZƴƴ | > | -- | -- | -- | -- | -- | ¥ ĸƬǙDZƴƴ | - + |
5g | ¥ ƬȍƉDZƴƴ | > | -- | -- | -- | -- | -- | ¥ ƬȍƉDZƴƴ | - + |
25g | ¥ ĸƴȍŶDZƴƴ | > | -- | -- | -- | -- | -- | ¥ ĸƴȍŶDZƴƴ | - + |
0g | ¥ ǙƉĸǙDZƴƴ | 6 | -- | -- | -- | -- | -- | ¥ ǙƉĸǙDZƴƴ | - + |
500g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
00g | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
171.37
[1]. Chawla JS, et al. Oral valganciclovir versus ganciclovir as delayed pre-emptive therapy for patients after allogeneic hematopoietic stem cell transplant: a pilot trial (0-027) and review of the literature. Transpl Infect Dis. 2012 Jun;1(3):259-67.
[2]. O'Brien S, et al. Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy. Blood. 200 Feb 15;111():116-9.
[3]. Sugawara M, et al. Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. J Pharm Sci. 2000 Jun;9(6):71-9.
P261-P26-P270-P271-P20-P302+P352-P30+P30-P305+P351+P33-P330-P362+P36-P03+P233-P05-P501